Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
Protect Drug Innovation Act This bill repeals several programs and requirements that were enacted under the Inflation Reduction Act of 2022 relating to the prices of prescription drugs, including (1) the Medicare Drug Price Negotiation Program, (2) provisions that require drug manufacturers to issue rebates for certain drugs under Medicare for which prices increase faster than inflation, and (3) provisions that cap annual out-of-pocket spending under the Medicare prescription drug benefit.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2023 · fourth_quarter · Health Issues
S. 150, the Affordable Prescriptions for Patients Act S. 127, the Pharmacy Benefit Manager Transparency Act HR 4343 - Organ Donation Clarification Act of 2023 S.1246 - SMART Prices Act H.R. 2748 - Contact Lens Prescription Modernization Act S.2157 - Protect Drug Innovation Act H.R. 5688 - Bipartisan HSA Improvement Act H.R. 5687 - HSA Modernization Act
Client expense: $60,000 · Firm income: Not reported
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Pharmacy
Issues related to implementation of the drug pricing provisions of the Inflation Reduction Act of 2022. H.R.485 - Protecting Health Care for All Patients Act of 2023 - opposed. S. 1264 - SMART Prices Act - in support. S. 1323 - End Price Gouging for Medications Act - in support. S. 2157 - A bill to repeal prescription drug price control provisions of the Inflation Reduction Act - opposed. S. 1339 - Pharmacy Benefit Manager Reform Act - in support. S. 1214 - RARE Act - in support. S. 1114 - Expanding Access to Low-Cost Generics Act of 2023 - in support. S.1067 - Ensuring Timely Access to Generics Act of 2023 - in support.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE